Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Seeks CMS Guidance On Preclinical Meetings, Trial Design

Executive Summary

Industry is seeking guidance from the Centers for Medicare & Medicaid Services on designing clinical trials to satisfy standards for Medicare national coverage decisions

You may also be interested in...



CMS Developing Guidance On Coverage Decisions For Clinical Trials

The Centers for Medicare & Medicaid Services will produce a guidance document on Medicare coverage of products used in clinical trials or registries

CMS Developing Guidance On Coverage Decisions For Clinical Trials

The Centers for Medicare & Medicaid Services will produce a guidance document on Medicare coverage of products used in clinical trials or registries

CMS Off-Label Coverage Decision For Colorectal Cancer Rx Coming Soon

The Centers for Medicare & Medicaid Services expects to release proposed national coverage determinations on off-label use of colorectal cancer drugs in the "near future," CMS Chief Medical Officer Sean Tunis, MD, said Sept. 30 at a CMS workshop in Baltimore

UsernamePublicRestriction

Register

LL035386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel